SCHEMBL20733227

SCHEMBL20733227

O=C(Nc1ncccn1)N1c2nc(-c3ccnc(C(F)(F)F)c3)ccc2N2CCC[C@H]1C2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDH2 P48735 3/20 0.40
▸ NR3C2 P08235 1/20 0.37
▸ PIK3CA P42336 3/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ GRM2 Q14416 2/20 0.36
▸ PDE4B Q07343 3/20 0.35
▸ PDE4D Q08499 2/20 0.35
▸ PDE4A P27815 1/20 0.35
▸ PDE4C Q08493 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ RPS6KB1 P23443 1/20 0.35
▸ AKT1 P31749 1/20 0.35
▸ CREBBP Q92793 1/20 0.34
▸ MAP4K4 O95819 1/20 0.34
▸ PIK3CD O00329 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16754346 0.91 IDH2 (0.40) IDH2NR3C2PIK3CACYP2C19GRM2
SCHEMBL17778564 0.91 IDH2 (0.40) IDH2NR3C2PIK3CACYP2C19GRM2
SCHEMBL16776481 0.88 HTR2C (0.41) IDH2CYP2C19LMNAHSD17B10
SCHEMBL16754635 0.88 FAAH (0.42) IDH2NR3C2PIK3CACYP2C19GRM2
SCHEMBL16754669 0.88 ROCK2 (0.37) IDH2NR3C2PIK3CACYP2C19GRM2
SCHEMBL17778302 0.88 ROCK2 (0.37) IDH2NR3C2PIK3CACYP2C19GRM2
SCHEMBL17778304 0.87 NR3C2 (0.38) IDH2NR3C2PIK3CACYP2C19GRM2
SCHEMBL16754405 0.87 NR3C2 (0.38) IDH2NR3C2PIK3CACYP2C19GRM2
SCHEMBL16754649 0.87 NR3C2 (0.38) IDH2NR3C2PIK3CACYP2C19GRM2
SCHEMBL17618458 0.86 TRPV1 (0.41) IDH2NR3C2PIK3CACYP2C19PDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190048016-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE IP NO 2 LTD (GB) 2019-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190048016-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS SIRT1, SIRT3, SIRT2 IDH2 34/4885NR3C2 4528/4885PIK3CA 4009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback